Abstract
In vivo phage display is a new approach to acquire peptide molecules that bind stably to a given target. Phage peptide display libraries have been selected in mice and humans and numerous vasculature-targeting peptides have been reported. However, in vivo phage display has not typically produced molecules that extravasate to target specific organ or tumor antigens. Phage selections in animals have been performed for very short times without optimization for biodistribution or clearance rates to a particular organ. It is hypothesized that peptides that home to a desired antigen/organ can be obtained from in vivo phage experiments by optimization of incubation times, phage extraction and propagation procedures. To accomplish this goal, one must first gain a better understanding of the in vivo biodistribution and rate of clearance of engineered phage peptide display libraries. While the fate of wild type phage in rodents has been reported, the in vivo biodistribution of the commonly used engineered fd-tet M13 phage peptide display libraries (such as in the fUSE5 vector system) have not been well established. Here we report the biodistribution and clearance properties of fd-tet fifteen amino acid random peptide display libraries in fUSE5 phage in three common mouse models employed for drug discovery – CF-1, nude, and SCID mice.
Article PDF
Similar content being viewed by others
References
Smith GP & Petrenko VA (1997) Chem. Rev. 97: 391–410.
Barbas CF, 3rd, Hu D, Dunlop N, Sawyer L, Cababa D, Hendry RM, Nara PL & Burton DR (1994) Proc. Nat. Acad. Sci. USA 91: 3809–3813.
Scott JK, Loganathan D, Easley RB, Gong X & Goldstein IJ (1992) Proc. Nat. Acad. Sci. USA 89: 5398–5402.
Dreier B, Beerli RR, Segal DJ, Flippin JD & Barbas CF, 3rd (2001) J. Biol. Chem. 276: 29466–29478.
Agris PF, Marchbank MT, Newman W, Guenther R, Ingram P, Swallow J, Mucha P, Szyk A, Rekowski P, Peletskaya E & Deutscher SL (1999) J. Prot. Chem. 18: 425–435.
Smith GP (1985) Science 228: 1315–1317.
Scott JK & Smith GP (1990) Science 249: 386–390.
Pratt D, Tzagoloff H & Beaudoin J (1969) Virology 39: 42–53.
Hoess RH (2001) Chem. Rev. 101: 3205–3218.
Smith GPLH (2003) http://www.biosci.missouri.edu/smithGP/.
Bastien N, Trudel M & Simard C (1997) Virology 234: 118–122.
Demangel C, Lafaye P & Mazie JC (1996) Molec. Immunol. 33: 909–916.
Grabowska AM, Jennings R, Laing P, Darsley M, Jameson CL, Swift L & Irving WL (2000) Virology 269: 47–53.
Wan Y, Wu Y, Bian J, Wang XZ, Zhou W, Jia ZC, Tan Y & Zhou L (2001) Vaccine 19: 2918–2923.
De Berardinis P, Sartorius R, Fanutti C, Perham RN, Del Pozzo G & Guardiola J (2000) Nat. Biotechnol. 18: 873–876.
Gaubin M, Fanutti C, Mishal Z, Durrbach A, De Berardinis P, Sartorius R, Del Pozzo G, Guardiola J, Perham RN & Piatier-Tonneau D (2003) DNA Cell Biol. 22: 11–18.
Willis AE, Perham RN & Wraith D (1993) Gene 128: 79–83.
Johnson DL, Farrell FX, Barbone FP, McMahon FJ, Tullai J, Hoey K, Livnah O, Wrighton NC, Middleton SA, Loughney DA, Stura EA, Dower WJ, Mulcahy LS, Wilson IA & Jolliffe LK (1998) Biochemistry 37: 3699–3710.
Atwell S & Wells JA (1999) Proc. Nat. Acad. Sci. USA 96: 9497–9502.
Peletskaya EN, Glinsky VV, Glinsky GV, Deutscher SL & Quinn TP (1997) J. Molec. Biol. 270: 374–384.
Landon LA, Peletskaya EN, Glinsky VV, Karasseva N, Quinn TP & Deutscher SL (2003) J. Prot. Chem. 22: 193–204.
Pasqualini R & Ruoslahti E (1996) Nature 380: 364–366.
Arap W, Pasqualini R & Ruoslahti E (1998) Science 279: 377–380.
Pasqualini R, Koivunen E & Ruoslahti E (1997) Nat. Biotechnol. 15: 542–546.
Arap W, Haedicke W, Bernasconi M, Kain R, Rajotte D, Krajewski S, Ellerby HM, Bredesen DE, Pasqualini R & Ruoslahti E (2002) Proc. Nat. Acad. Sci. USA 99: 1527–1531.
Curnis F, Arrigoni G, Sacchi A, Fischetti L, Arap W, Pasqualini R & Corti A (2002) Cancer Res. 62: 867–874.
Essler M & Ruoslahti E (2002) Proc. Nat. Acad. Sci. USA 99: 2252–2257.
Arap W, Kolonin MG, Trepel M, Lahdenranta J, Cardo-Vila M, Giordano RJ, Mintz PJ, Ardelt PU, Yao VJ, Vidal CI, Chen L, Flamm A, Valtanen H, Weavind LM, Hicks ME, Pollock RE, Botz GH, Bucana CD, Koivunen E, Cahill D, Troncoso P, Baggerly KA, Pentz RD, Do KA, Logothetis CJ & Pasqualini R (2002) Nat. Med. 8: 121–127.
Pasqualini R & Arap W (2002) An. Hematol. 81: S66–S67.
Pasqualini R, McDonald DM & Arap W (2001) Nat. Immunol. 2: 567–568.
Asai T, Nagatsuka M, Kuromi K, Yamakawa S, Kurohane K, Ogino K, Tanaka M, Taki T & Oku N (2002) FEBS Lett. 510: 206–210.
Asai T, Fukatsu H, Kuromi K, Ogino K, Tanaka M, Oku N & Taki T (2002) Biol. Pharm. Bull. 25: 904–906.
Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP & Jain RK (1998) Proc. Nat. Acad. Sci. USA 95: 4607–4612.
Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK & McDonald DM (2000) Am. J. Pathol. 156: 1363–1380.
McDonald DM & Baluk P (2002) Cancer Res. 62: 5381–5385.
Landon LA & Deutscher SL (2003) J. Cell. Biochem. 90: 509–517.
Shultz LD & Sidman CL (1987) Ann. Rev. Immunol. 5: 367–403.
Bosma MJ (1992) Immunodeficiency Rev. 3: 261–276.
Nonoyama S & Ochs HD (1996) Internat. Rev. Immunol. 13: 289–300.
Szabo P, Zhao K, Kirman I, Le Maoult J, Dyall R, Cruikshank W & Weksler ME (1998) J. Immunol. 161: 2248–2253.
Krishna R, Webb MS, St Onge G & Mayer LD (2001) Journal of Pharmacol. Experiment. Therapeut. 298: 1206–1212.
Pastorino F, Brignole C, Marimpietri D, Sapra P, Moase EH, Allen TM & Ponzoni M (2003) Cancer Res. 63: 86–92.
Gabizon A, Shmeeda H & Barenholz Y (2003) Clin. Pharmacokinetics 42: 419–436.
Yang MX, Shenoy B, Disttler M, Patel R, McGrath M, Pechenov S & Margolin AL (2003) Proc. Nat. Acad. Sci. USA 100: 6934–6939.
Yang XD, Corvalan JR, Wang P, Roy CM & Davis CG (1999) J. Leukocyte Biol. 66: 401–410.
Motulsky HJ & Ransnas LA (1987) FASEB J. 1: 365–374.
Lindstrom ML & Bates DM (1990) Biometrics 46: 673–687.
Steimer JL, Mallet A, Golmard JL & Boisvieux JF (1984) Drug Metabolism Rev. 15: 265–292.
Geier MR, Trigg ME & Merril CR (1973) Nature 246: 221–223.
Uhr JW & Weissman G (1965) J. Immunol. 94: 544–550.
Inchley CJ (1970) J. Immunol. 104: 14–18.
Inchley CJ & Howard JG (1969) Clin. Experiment. Immunol. 5: 189–198.
Inchley CJ (1969) Clin. Experiment. Immunol. 5: 173–187.
Ivanenkov VV, Felici F & Menon AG (1999) Biochim. Biophys. Acta. 1448: 463–472.
Molenaar TJ, de Hass SA, van Berkel TJ, Kuiper J & Biessen EA (2002) Virology 293: 182–183.
Yip YL, Hawkins NJ, Smith G & Ward RL (1999) J. Immunol. Meth. 225: 171–178.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zou, J., Dickerson, M.T., Owen, N.K. et al. Biodistribution of filamentous phage peptide libraries in mice. Mol Biol Rep 31, 121–129 (2004). https://doi.org/10.1023/B:MOLE.0000031459.14448.af
Issue Date:
DOI: https://doi.org/10.1023/B:MOLE.0000031459.14448.af